Next Frontier Capital, Sears Capital, Z Investments and others back SiteOne
Bozeman, Montana-based SiteOne Therapeutics, a developer of new drugs, has secured an undisclosed amount of funding. The investors included Next Frontier Capital, 2M Companies Inc, Sears Capital Management, Biobrit LLC, Mission Bay Capital and Z Investments. In addition to the funding, Will Price, founder and managing partner of Next Frontier Capital, has been added to SiteOne's board of directors.
20 July 2015•3 mins read
